Association of p73 G4C14-to-A4T14 polymorphism with human papillomavirus type 16 status in squamous cell carcinoma of the head and neck in non-hispanic whites

Cancer

Volumn 115, Issue 8, 2009, Pages 1660-1668

  Ji, Xuemei ^b,c   Sturgis, Erich M ^b   Zhao, Chong ^b   Etzel, Carol J ^b   Wei, Qingyi ^b   Li, Guojun ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c WUHAN UNIVERSITY   (China)

Author keywords

Genetic susceptibility; Human papillomavirus; Molecular epidemiology; p73 polymorphism; Squamous cell carcinoma of the head and neck

Indexed keywords

GENOMIC DNA; HUMAN PAPILLOMAVIRUS TYPE 16 ONCOPROTEIN; ONCOPROTEIN; PROTEIN P73; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ADULT; AGED; ARTICLE; CANCER RISK; DNA POLYMORPHISM; ETHNICITY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; HEAD AND NECK CARCINOMA; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; MAJOR CLINICAL STUDY; MALE; OROPHARYNX CANCER; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEAD AND NECK NEOPLASMS; HUMAN PAPILLOMAVIRUS 16; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; POLYMORPHISM, GENETIC;

EID: 65249172586     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24184     Document Type: Article

References (57)

1. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK. Head and neck cancer. N Engl J Med. 1993;328:184-194.
2. Sturgis EM, Cinciripini PM. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer. 2007;110:1429-1435.
3. Shiboski CH, Schmidt BL, Jordan RC. Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years. Cancer. 2005;103:1843-1849.
4. Fakhry C, Gillison ML. Clinical implications of human papillomavirus in head and neck cancers. J Clin Oncol. 2006;24:2606-2611.
5. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of papillomaviruses. Virology. 2004;324:17-27.
6. Chellappan S, Kraus VB, Kroger B, et al. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. Proc Natl Acad Sci USA. 1992;89:4549-4553.
7. Phillips AC, Vousden KH. E2F-1 induced apoptosis. Apoptosis. 2001;6:173-182.
8. Weinberg RA. Oncogenes and tumor suppressor genes. CA Cancer J Clin. 1994;44:160-170.
9. Park JS, Kim EJ, Lee JY, Sin HS, Namkoong SE, Um SJ. Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by human papillomavirus E6 proteins. Int J Cancer. 2001;91:822-827.
10. Das S, Somasundaram K. Therapeutic potential of an adenovirus expressing p73 beta, a p53 homologue, against human papilloma virus positive cervical cancer in vitro and in vivo. Cancer Biol Ther. 2006;5:210-217.
11. Brooks LA, Sullivan A, O'Nions J, et al. E7 proteins from oncogenic human papillomavirus types transactivate p73:role in cervical intraepithelial neoplasia. Br J Cancer. 2002;86:263-268.
12. Gillison ML, Shah KV. Human papillomavirus-associated head and neck squamous cell carcinoma: mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers. Curr Opin Oncol. 2001;13:183-188.
13. Gillison ML, D'Souza G, Westra W, et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst. 2008;100:407-420.
14. Wiest T, Schwarz E, Enders C, Flechtenmacher C, Bosch FX. Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control. Oncogene. 2002;21:1510-1517.
15. Andl T, Kahn T, Pfuhl A, et al. Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. Cancer Res. 1998;58:5-13.
16. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000;92:709-720.
17. Ritchie JM, Smith EM, Summersgill KF, et al. Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer. 2003;104:336-344.
18. Mellin H, Friesland S, Lewensohn R, Dalianis T, Munck- Wikland E. Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. Int J Cancer. 2000;89:300-304.
19. Li W, Thompson CH, O'Brien CJ, et al. Human papilloma- virus positivity predicts favourable outcome for squamous carcinoma of the tonsil. Int J Cancer. 2003;106:553-558.
20. Lindel K, Beer KT, Laissue J, Greiner RH, Aebersold DM. Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma. Cancer. 2001;92:805-813.
21. Li G, Sturgis EM, Wang LE, et al. Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of squa- mous cell carcinoma of the head and neck. Carcinogenesis. 2004;25:1911-1916.
22. Li G, Zhai X, Zhang Z, Chamberlain RM, Spitz MR, Wei Q. MDM2 gene promoter polymorphisms and risk of lung cancer: a case-control analysis. Carcinogenesis. 2006;27: 2028-2033.
23. Li G, Liu Z, Sturgis EM, et al. Genetic polymorphisms of p21 are associated with risk of squamous cell carcinoma of the head and neck. Carcinogenesis. 2005;26:1596-1602.
24. Kaghad M, Bonnet H, Yang A, et al. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell. 1997;90:809-819.
25. Hamajima N, Saito T, Matsuo K, Kozaki K, Takahashi T, Tajima K. Polymerase chain reaction with confronting 2-pair primers for polymorphism genotyping. Jpn J Cancer Res. 2000;91:865-868.
26. Hamajima N, Matsuo K, Suzuki T, et al. No associations of p73 G4C14-to-A4T14 at exon 2 and p53 Arg72Pro polymorphisms with the risk of digestive tract cancers in Japanese. Cancer Lett. 2002;181:81-85.
27. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer. 1993;54:594-606.
28. Tachezy R, Klozar J, Salakova M, et al. HPV and other risk factors of oral cavity/oropharyngeal cancer in the Czech Republic. OralDis. 2005;11:181-185.
29. Makowska W, MalejczykM, Kapiszewska D, Nyckowska J, Wojcikiewicz E, Wroblewska B. [Human papillomavirus (HPV) in the laryngeal carcinoma.] Otolaryngol Pol. 2001;55:263-266.
30. Syrjanen S. HPV infections and tonsillar carcinoma. J Clin Pathol. 2004;57:449-455.
31. Syrjanen S. Human papillomavirus (HPV) in head and neck cancer. J Clin Virol. 2005;32(suppl 1):S59-S66.
32. Bandyopadhyay S, Chatterjee R. HPV viral load determination during pregnancy as a possible cervical cancer risk. J Exp Clin Cancer Res. 2006;25:29-38.
33. Al-Maghrabi JA. The role of human papillomavirus infection in prostate cancer. Saudi Med J. 2007;28:326-333.
34. Moscicki AB, Schiffman M, Kjaer S, Villa LL. Chapter 5: updating the natural history of HPV and anogenital cancer. Vaccine. 2006;24(suppl 3):S42-S51.
35. Castillo A, Aguayo F, Koriyama C, et al. Human papillo- mavirus in esophageal squamous cell carcinoma in Colombia and Chile. World J Gastroenterol. 2006;12:6188-6192.
36. Syrjanen KJ. HPV infections and lung cancer. J Clin Pathol. 2002;55:885-891.
37. Karagas MR, Nelson HH, Sehr P, et al. Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. J Natl Cancer Inst. 2006;98:389-395.
38. De Petrini M, Ritta M, Schena M, et al. Head and neck squamous cell carcinoma: role of the human papillomavirus in tumour progression. New Microbiol. 2006;29:25-33.
39. Schwartz SM, Daling JR, Doody DR, et al. Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst. 1998;90:1626-1636.
40. Matsha T, Donninger H, Erasmus RT, Hendricks D, Stepien A, Parker MI. Expression of p53 and its homolog, p73, in HPV DNA positive oesophageal squamous cell carcinomas. Virology. 2007;369:182-190.
41. Yang A, Walker N, Bronson R, et al. p73-Deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature. 2000;404:99-103.
42. Li G, Sturgis EM. The role of human papillomavirus in squamous carcinoma of the head and neck. Curr Oncol Rep. 2006;8:130-139.
43. Perrone F, Mariani L, Pastore E, et al. p53 Codon 72 polymorphisms in human papillomavirus-negative and human papillomavirus-positive squamous cell carcinomas of the oropharynx. Cancer. 2007;109:2461-2465.
44. Madeleine MM, Shera K, Schwartz SM, et al. The p53 Arg72Pro polymorphism, human papillomavirus, and invasive squamous cell cervical cancer. Cancer Epidemiol Bio- markers Prev. 2000;9:225-227.
45. Dahlstrom KR, Adler-Storthz K, Etzel CJ, et al. Human papillomavirus type 16 infection and squamous cell carcinoma of the head and neck in never-smokers: a matched pair analysis. Clin Cancer Res. 2003;9:2620-2626.
46. Hammarstedt L, Lindquist D, Dahlstrand H, et al. Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer. 2006;119:2620-2623.
47. Favre A, Paoli D, Poletti M, et al. The human palatine tonsil studied from surgical specimens at all ages and in various pathological conditions. 1. Morphological and structural analyses. Z Mikrosk Anat Forsch. 1986;100:7-33.
48. Kornfehl J, Hager G, Gedlicka C, Formanek M. Ethanol decreases negative cell-cycle-regulating proteins in a head and neck squamous cell carcinoma cell line. Acta Otolaryngol. 2002;122:338-342.
49. Guo W, Baluda MA, Park NH. Ethanol upregulates the expression of p21 WAF1/CIP1 and prolongs G1 transition via a p53-independent pathway in human epithelial cells. Oncogene. 1997;15:1143-1149.
50. Shao H, Zhou J, Ewald SJ. Regulation of signal transduc- tion and DNA fragmentation in thymocytes by ethanol. Cell Immunol. 1995;164:11-19.
51. Hsu TC, Furlong C. The role of ethanol in oncogenesis of the upper aerodigestive tract; inhibition of DNA repair. Anticancer Res. 1991;11:1995-1998.
52. Herrero R, Castellsague X, Pawlita M, et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst. 2003;95:1772-1783.
53. Kreimer AR, Clifford GM, Boyle P, et al. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev. 2005;14:467-475.
54. Gillison ML, D'Souza G, Westra W, et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst. 2008;100:407-420.
55. Koskinen WJ, Chen RW, Leivo I, et al. Prevalence and physical status of human papillomavirus in squamous cell carcinomas of the head and neck. Int J Cancer. 2003;107:401-406.
56. Mork J, Lie AK, Glattre E, et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med. 2001;344:1125-1131.
57. Huang CC, Qiu JT, Kashima ML, et al. Generation of type-specific probes for the detection of single-copy human papillomavirus by a novel in situ hybridization method. Mod Pathol. 1998;11:971-977.